All News

Top news of the day from across the health care industry.

Patients with multiple sclerosis who consumed 2 cans of soda per day were 5 times more likely to experience severe disability.

Solriamfetol (Sunosi, Jazz Pharmaceuticals) is the first dual-acting dopamine and norepinephrine reuptake inhibitor approved for this indication.

The impact has been a continual struggle for pharmacies to provide adequate and appropriate patient care.

You have a passion for helping people feel better, live longer, and enjoy life more. But, is your current place of employment allowing you to do that?

Mrs. Winslow's Soothing Syrup, created in 1849, contained morphine and alcohol and was recommended in high doses.

When combined, treatment with metformin and heme suppressed tumor growth in mice.

A pilot study suggests compounds found in coffee may slow the growth of prostate cancer.

Top news of the day from across the health care industry.

Higher body mass index at beginning of menstruation linked to greater risk of developing multiple sclerosis.

With patient pay responsibility expected to climb 50% of every health care dollar by 2020, solutions to streamlining reimbursement may help.

Lawsuit alleges that patients paid artificially high prices for brand-name Humira, and that they were deprived of the benefits of early, robust competition from biosimilars as a result of wrongful conduct.

According to the report, approximately 80% of new HIV transmissions are from people who do not know they have HIV infection or are not receiving regular care.

Operating a specialty pharmacy is a great benefit to health systems that adopt it early, while those who wait are going to face higher risks and have a lower probability of success.

The phase 3 RELAY trial met its primary endpoint in significantly improving progression-free survival in metastatic EGFR-mutated non-small cell lung cancer.

Top news of the day from across the health care industry.

A simple, compact laser probe is an opportunity for early detection of melanoma, the deadliest form of skin cancer.

Aimmune’s Biologics License Application for AR101 under evaluation as a treatment to reduce the risk of anaphylaxis in peanut-allergic children and adolescents following exposure to peanut.

This therapy is expected to become available in late June.

The risks are too high for the pharmacy to be cavalier regarding compliance with antifraud laws.

The framework describes the cyclic nature of medication access, beginning with the patient’s awareness of their illness or condition, and ending with adherence.

Extensive-stage small cell lung cancer is a difficult-to-treat, aggressive type of cancer with limited treatment options.

Specialty therapies for autoimmune diseases and cancer topped the list of biggest-selling drugs for 2018.

Study finds patients with negative beliefs about medications may be more likely to experience adverse effects when taking antiretroviral therapy.

This approval is based on results from the Phase III IMpower133 study, which showed that atezolizumab in combination with chemotherapy helped people live significantly longer compared to chemotherapy alone in the intention-to-treat population.

Top news of the day from across the health care industry.

Levoleucovorin injection is being recalled due to the presence of copper salts discovered during a 12-month stability testing.

As a result of the agreement, Teva is licensed to launch a generic version of liraglutide (Victoza, Novo Nordisk) as of December 22, 2023.